ST
Sarika Thapan
About Sarika Thapan
Data last updated:
Sarika Thapan is a Director at Dayton Pharmaceuticals Private Limited (since 2015). The company operates in Trading. Dayton Pharmaceuticals Private Limited reported revenue of ₹40.8 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dayton Pharmaceuticals Private Limited U52100UP2015PTC070115 | Director | 15 Apr 2015 | 2015 | ₹40.8 Lakh (FY 2024) | Active |
Board colleagues of Sarika Thapan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Akhil Kumar Thapan | 07132261 | Dayton Pharmaceuticals Private Limited | Director |
| Anushi Agarwal | 08700805 | Dayton Pharmaceuticals Private Limited | Director |
| Nitin Gupta | 09750914 | Dayton Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sarika Thapan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sarika Thapan
Sarika Thapan currently holds 1 directorship: Dayton Pharmaceuticals Private Limited (Director, since 15 Apr 2015, revenue ₹40.8 Lakh (FY 2024)).
Sarika Thapan was first appointed on 15 Apr 2015 as Director at Dayton Pharmaceuticals Private Limited.
The current boards of Sarika Thapan's companies include Akhil Kumar Thapan (Dayton Pharmaceuticals Private Limited), Anushi Agarwal (Dayton Pharmaceuticals Private Limited), Nitin Gupta (Dayton Pharmaceuticals Private Limited).